CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Editas Medicine Inc. (EDIT) on Wednesday reported a loss of $40.3 million in its second quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 56 cents.
The results beat Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of 76 cents per share.
The genome editing company posted revenue of $2.9 million in the period, which did not meet Street forecasts. Five analysts surveyed by Zacks expected $6.3 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EDIT at https://www.zacks.com/ap/EDIT
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
